Royal London Asset Management LTD Pfizer Inc Transaction History

Royal London Asset Management LTD

$39.3 Billion
Q1 2024

A detailed history of Royal London Asset Management LTD transactions in Pfizer Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 2,348,479 shares of PFE stock, worth $65.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,348,479

Previous 2,351,546 0.13%

Holding current value

$65.7 Million

Previous $67.7 Million 3.74%

% of portfolio

0.17%

Previous 0.2%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $79,404 - $91,181	-3,067 Reduced 0.13%	2,348,479 $65.2 Million
Q4 2023 Feb 13, 2024	BUY	$26.13 - $33.94 $999,106 - $1.3 Million	38,236 Added 1.65%	2,351,546 $67.7 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $3.63 Million - $4.25 Million	113,175 Added 5.14%	2,313,310 $76.7 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $6.7 Million - $7.76 Million	185,592 Added 9.21%	2,200,135 $80.7 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $819,469 - $1.07 Million	20,804 Added 1.04%	2,014,543 $82.2 Million

Q4 2022 Feb 09, 2023	BUY	$41.75 - $54.5 $3.18 Million - $4.15 Million	76,235 Added 3.98%	1,993,739 $102 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $2.88 Million - $3.51 Million	-65,790 Reduced 3.32%	1,917,504 $84.1 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $694,739 - $823,743	14,931 Added 0.76%	1,983,294 $104 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $3.48 Million - $4.31 Million	75,957 Added 4.01%	1,968,363 $102 Million
Q4 2021 Oct 18, 2022	SELL	$41.32 - $61.25 $2.89 Million - $4.28 Million	-69,889 Reduced 3.56%	1,892,406 $112 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $2.89 Million - $4.28 Million	-69,889 Reduced 3.56%	1,892,406 $112 Million
Q3 2021 Oct 18, 2022	SELL	$39.25 - $50.42 $2.03 Million - $2.61 Million	-51,677 Reduced 2.57%	1,962,295 $84.4 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $2.03 Million - $2.61 Million	-51,677 Reduced 2.57%	1,962,295 $84.4 Million
Q2 2021 Oct 18, 2022	BUY	$35.91 - $40.68 $1.1 Million - $1.25 Million	30,678 Added 1.55%	2,013,972 $78.9 Million
Q2 2021 Jul 14, 2021	SELL	$35.91 - $40.68 $1.51 Million - $1.71 Million	-42,143 Reduced 2.05%	2,013,972 $78.9 Million
Q1 2021 Oct 17, 2022	BUY	$33.49 - $37.77 $2.44 Million - $2.75 Million	72,821 Added 3.67%	2,056,115 $74.5 Million
Q1 2021 Apr 13, 2021	BUY	$33.49 - $37.77 $861,061 - $971,104	25,711 Added 1.27%	2,056,115 $74.5 Million
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $2.95 Million - $3.76 Million	-88,238 Reduced 4.16%	2,030,404 $74.7 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $239,903 - $281,461	-7,556 Reduced 0.36%	2,118,642 $76.6 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $2.01 Million - $2.44 Million	-66,718 Reduced 3.04%	2,126,198 $69.4 Million
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $500,946 - $715,744	-18,533 Reduced 0.84%	2,192,916 $71.7 Million
Q4 2019 Feb 05, 2020	BUY	$32.92 - $37.36 $1.28 Million - $1.45 Million	38,765 Added 1.78%	2,211,449 $86.1 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $2.03 Million - $2.63 Million	-62,394 Reduced 2.79%	2,172,684 $78.1 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $3.16 Million - $3.55 Million	-85,513 Reduced 3.68%	2,235,078 $96.9 Million
Q1 2019 Apr 30, 2019	SELL	$37.5 - $41.2 $6.35 Million - $6.98 Million	-169,449 Reduced 6.81%	2,320,591 $0
Q4 2018 Jan 29, 2019	BUY	$38.47 - $43.86 $6.46 Million - $7.36 Million	167,837 Added 7.23%	2,490,040 $107 Million
Q3 2018 Nov 08, 2018	SELL	$34.47 - $41.81 $4.62 Million - $5.6 Million	-134,012 Reduced 5.46%	2,322,203 $0
Q2 2018 Sep 19, 2018	BUY	$32.98 - $35.16 $81 Million - $86.4 Million	2,456,215 New	2,456,215 $89.1 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Pfizer Inc Transaction History